维普期刊资源整合服务平台（V6.5）

328篇 您的检索式：作者名="Parving HH"

选中清除导出查看参考文献查看引证文献引用追踪共17页首页上一页第1页下一页末页 /17 跳转

	题名	作者	年代	出处	被引量
1	Effect of a multifactorial intervention on mortality in type 2 diabetes显示文摘	Gaede P Parving HH Pedersen O		New England Journal of Medicine0，，：	3
2	Effect of a multifactorial intervention on mortality in type 2 diabetes显示文摘	Goede P Lund-Andersen H Parving HH	2008	N Engl J Med2008，358，6：	1
3	Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy显示文摘	Sato A Tarnow L Parving HH	1998	Diabetes Care1998，21，9：	1
4	Albuminuria atherapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy 显示文摘	De Zeeuw D Remuzzi G Parving HH	2004	Circulation2004，110，8：	1
5	The Effect of Irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes显示文摘	Parving HH Lehnert H Brochner-Mortensen J	2001	New Engl J Med2001，345，12：	1
6	显示文摘	Parving HH Lehnert H Broehner-Mortensen J	2001	N Engl J Med2001，345，12：	1
7	The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabettes显示文摘	Parving HH Lehnert H Brochner MJ	2001	N Engl J Med2001，345，9：	1
8	Aliskiren combined with losartan in type 2 diabetes and nephropathy 显示文摘	Parving HH Persson F Lewis JB	2008	N Engl J Med2008，358，23：	1
9	Stroke in pa- tients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience显示文摘	Skali H Parving HH Parfrey PS	2011	Circulation2011，124，25：	1
10	Effect of a mul-tifactorial intervention on mortality in type 2 diabetes显示文摘	Gaede P Lund-Andersen H Parving HH	2008	N En-gl J Med2008，358，：	1
11	Aliskiren combined with losartan in type 2 diabetes and nephropathy显示文摘	PARVING HH PERSSON F LEWIS JB	2008	N Engl J Med2008，358，23：	1
12	Cardiorenal end points in atrial of aliskiren for type 2 diabetes显示文摘	Parving HH Brenner BM McMurray J J	2012	N Engl J Med2012，367，23：	1
13	Albuminuria,a thera-peutic target for cardiovascular protection in type 2 diabeticpatients with nephropathy 显示文摘	de Zeeuw D Remuzzi G Parving HH	2004	Circulation2004，110，8：	1
14	Aliskiren combined with losartan in type 2 diabetes and nephropathy显示文摘	Parving HH Persson F Lewis JB	2008	N Engl J Med2008，358，23：	1
15	Glomerular structure and function in diabetic nephropathy early to advanced stages显示文摘	Osterby R Parving HH Hommel E	1990	Diabetes1990，39，9：	1
16	The effece of irbesartan on the development of diabetic nephroparhy in patients with type 2 diabetes显示文摘	Parving HH Lennert H	2001	N Engl J M ed2001，345，12：	1
17	Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus显示文摘	Hollenberg NK Parving HH Viberti G	2007	J Hypertens2007，25，9：	1
18	Effect of a multifactorial intervention on mortality in Type 2 diabetes显示文摘	Gaede P Lund-Andersen H Parving HH	2008	N Engl J Med2008，358，6：	1
19	Aliskiren combined with losartan in type 2diabetes and nephropathy显示文摘	Parving HH Persson F Lewis JB	2008	N Engl J Med2008，358，23：	1
20	Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes显示文摘	G(e)de P Vedel P Larsen N Jensen GVH Parving HH Pederson O	2003	N Engl J Med2003，348，5：	1

返回顶部每页显示：

共17页首页上一页第1页下一页末页 /17 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示